Clinical trials can assess impact of a medication on a disease. The ideal design is ‘blind’ – when the researchers and participants do not know who is assigned to the different treatments.
L’expertise universitaire, l’exigence journalistique
Articles sur Clinical trials
Affichage de 81 à 100 de 174 articles
People with Down syndrome are at much higher risk of dementia than the general population. Knowing when cognitive changes start is critical for developing new drugs.
These four “natural” therapies for depression have rigorous, peer-reviewed scientific studies to support their use.
Alzheimer’s disease affects many people under the age of 65. The ‘young-onset’ version of the disease is often misdiagnosed as depression or dismissed as a midlife crisis.
A large trial to test whether rebooting the immune system will help patients with Crohn’s disease has just begun.
The strengths of blockchain technologies could help address the weaknesses of health care systems to store and secure medical records.
An autoimmune disease called vitiligo causes white spots to appear on the body, in some cases completely erasing an individual’s pigmentation. But a new therapy is on the horizon.
Clinical trials involving probiotics are failing to report on the safety and harms of these treatments.
As medicines, not all cannabis products are created equal.
Stating a majority of people won’t benefit from a vaccine ignores the purpose of immunisation programs.
African countries should be looking to initiate or host more clinical trials to improve the continent’s health systems.
You should be aware of the amount of genetic information you might disclose in a research study – and what the benefits and risks will be.
In this clinical trial, the first of its kind, physicians explore whether directly applying a ‘good’ strain of bacteria to the skin can heal eczema
Study of the “memory centres” of the brain in adults offers hope for detecting Alzheimer’s disease earlier – before the onset of memory loss.
All multiple sclerosis sufferers have stem cells with the potential to heal them, but scientists are only just figuring out how to kick them into action.
Health Canada is proposing to allow some prescription drugs into the country with only ‘cursory clinical review.’ Here’s why we should be worried.
Coordinated international efforts may be key to improving the life expectancy and health of many snakebite victims.
There are several things we can do to speed up the development of new drugs, without putting patients at risk.
How a technology born from finance – the blockchain – can help the pharmaceutical industry to carry out clinical trials that protect patients.
For some patients, drilling a hole in the skull and inserting an electrode into the ‘sadness centre’ of the brain offers relief from debilitating and otherwise treatment-resistant depression.
Les contributeurs les plus fréquents
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Director of the Oxford Empathy Programme, University of Oxford
-
Epidemiologist, Cochrane
-
Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto
-
Distinguished Professor and Head of the Department of Pharmacy Practice, University of Connecticut
-
Professor of medicine, epidemiology & biostatistics, and philosophy, Western University
-
Professor of Immunology, RMIT University
-
Professor of Medicine, Monash University
-
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
-
Senior Research Fellow, Bioethics, University of Sydney
-
Adjunct Clinical Associate Professor, AMREP Department of Medicine, Alfred Hospital, Melbourne & Senior Medical Oncologist and Palliative Care Physician, Melbourne Oncology Group, Cabrini Haematology and Oncology Centre, Wattletree Road, Malvern, Monash University
-
Head, Cancer Research Program, Monash University
-
Senior Lecturer in Medical Ethics and Law, St George's, University of London
-
Associate professor, UNSW
-
Researcher, L’Université d’Ottawa/University of Ottawa
